Novavax Inc (NAS:NVAX)
$ 9.44 0.32 (3.51%) Market Cap: 1.51 Bil Enterprise Value: 643.71 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Q3 2020 Novavax Inc Earnings Call - Q&A Transcript

Nov 10, 2020 / 09:30PM GMT
Release Date Price: $78.74 (-12.81%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Novavax Third Quarter 2020 Financial Results Live Q&A Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker, Ms. Silvia Taylor, Senior Vice President of Investor Relations and Corporate Affairs. Please go ahead.

Silvia Taylor
Novavax, Inc. - SVP of IR & Corporate Affairs

Well, good afternoon, and thank you to everyone who has joined today's call and webcast. Yesterday, we hosted our third quarter 2020 operational highlights and financial results conference call. Unfortunately, due to technical issues, we were unable to conduct a Q&A session. The purpose of today's call is for the investment community to pose questions related to our third quarter 2020 financial and operating results.

As a reminder, a press release announcing third quarter results and an audio archive of yesterday's call are currently available on our website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot